Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro
Lai Jin(Nanjing Medical University), Shengnan Li(Nanjing Medical University)
Cited by 31
Related Papers
Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin‐releasing factor type 1 receptors
|British Journal of Pharmacology|2009|36
Urocortin induced expression of COX‐2 and ICAM‐1 via corticotrophin‐releasing factor type 2 receptor in rat aortic endothelial cells
|British Journal of Pharmacology|2009|26
Urocortin increased endothelial ICAM1 by cPLA2-dependent NF-κB and PKA pathways in HUVECs
|Journal of Molecular Endocrinology|2013|23
Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A2 and migration in prostate cancer cell RM-1
|Journal of Molecular Endocrinology|2014|22
Dihydrotestosterone alters urocortin levels in human umbilical vein endothelial cells
|Journal of Endocrinology|2013|7